Beam Therapeutics BEAM Asset turnover

Asset turnover at other companies

Vertex PharmaceuticalsVRTX

0.5×0.0×

Arrowhead ResearchARWR

0.3×-0.1×

Ultragenyx PharmaceuticalRARE

0.6×+0.1×

MGN

MagniteMGNI

0.2×0.0×

Wave Life SciencesWVE

0.5×+0.3×

Intellia TherapeuticsNTLA

0.1×0.0×

FAQ

What is Beam Therapeutics's asset turnover?

Beam Therapeutics (BEAM) reported asset turnover of 0.1× in Q1 2026.

How has Beam Therapeutics's asset turnover changed year-over-year?

Beam Therapeutics's asset turnover increased by 147.3% year-over-year, from 0× to 0.1×.

What is the long-term trend for Beam Therapeutics's asset turnover?

Over 5 years (2020 to 2025), Beam Therapeutics's asset turnover has grown at a 304.4% compound annual growth rate (CAGR), from 0× to 0.1×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.